As the 44th annual meeting of the European Association for the Study of the Liver (EASL) swung into high gear Thursday, data from Anadys Pharmaceuticals Inc., Schering-Plough Corp. and Salix Pharmaceuticals Ltd. garnered headlines. (BioWorld Today) Read More
